Pro Medicus (ASX:PME) has signed an A$5 million contract for the use of its Visage 7 enterprise viewer technology with Zwanger-Pesiri.
Under the five-year contract, Zwanger-Pesiri will use Visage 7 for primary diagnosis and clinical distribution of medical images.
This enables the group to fast, state-of-the-art imaging to their reading radiologists and referring physicians.
Zwanger-Pesiri is one of the largest US providers of outpatient imaging services with 18 imaging centres and 58 radiologists, regionally distributed across Long Island
In November, the company signed an A$8 million, seven-year contract with WellSpan Health – a large regional health network in the United States.
Under the agreement, PME's Visage 7 technology will be used throughout the WellSpan network for primary diagnosis, as well as clinical distribution of diagnostic images.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.